ClinicalTrials.gg
Drug

Emricasan clinical trials

Also written IDN-6556 and PF-03491390.

studies test it
17
open now
0
in phase 3
0
first study started
2003

How each study uses emricasan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

emricasan
13
Emricasan (5 mg)
2

Development codes

IDN-6556
13
PF-03491390
7
PF-013491390
1

Studies by the year they started

17 studies that test it; most in 2014 (6)

Studies that test emricasan, by start year
YearStudies
20031
20041
20121
20132
20146
20163
20172
20211

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
12
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 16 · Other 1

Conatus Pharmaceuticals Inc. (12) · Meridian Bioscience, Inc. (2) · Histogen (2) · University of Alberta (1)

Studies

Open first, then newest update. How each study uses emricasan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 17

Codes

What other systems call emricasan · ClinicalTrials.gg INT004657

  • UNII (FDA) P0GMS9N47QEMRICASANConfirmed FDA, Wikidata
  • Wikidata Q27077178emricasanConfirmed FDA, Wikidata
  • NCI Thesaurus C76660EmricasanOne source FDA
  • DrugBank DB05408One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.